NO980574L - (1S,2S)-1-(4-Hydroksyfenyl)-2-(4-hydroksy-4-fenylpiperidin-1-yl)-1-propanol-metansulfonattrihydrat - Google Patents

(1S,2S)-1-(4-Hydroksyfenyl)-2-(4-hydroksy-4-fenylpiperidin-1-yl)-1-propanol-metansulfonattrihydrat

Info

Publication number: NO980574L
Authority: NO; Norway
Prior art keywords: phenylpiperidine; hydroxyphenyl; hydroxy; propanol methanesulfonate; methanesulfonate
Prior art date: 1995-08-11

Application number

NO980574A

Other languages

English (en)

Other versions

NO310458B1 (no

NO980574D0 (no

Inventor

Marta Maria Andino

Terry Gene Sinay

Eugene Fred Fiese

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-11

Filing date

1998-02-10

Publication date

1998-02-10

1998-02-10 Application filed by Pfizer filed Critical Pfizer

1998-02-10 Publication of NO980574D0 publication Critical patent/NO980574D0/no

1998-02-10 Publication of NO980574L publication Critical patent/NO980574L/no

2001-07-09 Publication of NO310458B1 publication Critical patent/NO310458B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Virology (AREA)
Diabetes (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)

NO19980574A 1995-08-11 1998-02-10 (1S,2S)-1-(4-hydroksyfenyl)-2-(4-hydroksy-4-fenylpiperidin-1- yl)-1-propanol-metansulfonattrihydrat, anvendelse derav samtfarmasöytisk preparat NO310458B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US223895P	1995-08-11	1995-08-11
PCT/IB1996/000592 WO1997007098A1 (en)	1995-08-11	1996-06-20	(1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate

Publications (3)

Publication Number	Publication Date
NO980574D0 NO980574D0 (no)	1998-02-10
NO980574L true NO980574L (no)	1998-02-10
NO310458B1 NO310458B1 (no)	2001-07-09

Family

ID=21699847

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19980574A NO310458B1 (no)	1995-08-11	1998-02-10	(1S,2S)-1-(4-hydroksyfenyl)-2-(4-hydroksy-4-fenylpiperidin-1- yl)-1-propanol-metansulfonattrihydrat, anvendelse derav samtfarmasöytisk preparat

Country Status (41)

Country	Link
US (1)	US6008233A (no)
EP (1)	EP0843661B1 (no)
JP (1)	JP3099072B2 (no)
KR (1)	KR100291882B1 (no)
CN (2)	CN1198739A (no)
AP (1)	AP755A (no)
AR (1)	AR004676A1 (no)
AT (1)	ATE215072T1 (no)
AU (1)	AU710984B2 (no)
BG (1)	BG63678B1 (no)
BR (1)	BR9610766A (no)
CA (1)	CA2228752C (no)
CO (1)	CO4750830A1 (no)
CZ (1)	CZ296236B6 (no)
DE (1)	DE69620191T2 (no)
DK (1)	DK0843661T3 (no)
DZ (1)	DZ2083A1 (no)
ES (1)	ES2170857T3 (no)
GT (1)	GT199600051A (no)
HR (1)	HRP960372B1 (no)
HU (1)	HUP9802862A3 (no)
IL (1)	IL122649A (no)
IS (1)	IS1945B (no)
MA (1)	MA23957A1 (no)
NO (1)	NO310458B1 (no)
NZ (1)	NZ309134A (no)
OA (1)	OA10664A (no)
PE (1)	PE4898A1 (no)
PL (1)	PL185603B1 (no)
PT (1)	PT843661E (no)
RO (1)	RO120134B1 (no)
RS (1)	RS49521B (no)
RU (1)	RU2140910C1 (no)
SA (1)	SA96170171B1 (no)
SK (1)	SK284209B6 (no)
TN (1)	TNSN96104A1 (no)
TR (1)	TR199800208T1 (no)
TW (1)	TW495502B (no)
UA (1)	UA59341C2 (no)
WO (1)	WO1997007098A1 (no)
ZA (1)	ZA966760B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ284852A (en) *	1994-08-18	1998-06-26	Pfizer	3-(piperidin-1-yl)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidin-1-yl) alkanol derivatives; medicaments; used as a neuroprotective agent
UA59341C2 (uk) *	1995-08-11	2003-09-15	Пфайзер, Інк.	(1s,2s)-1-(4-гідроксифеніл)-2-(4-гідрокси-4-фенілпіперидин-1-іл)-1-пропанолметансульфонат тригідрат
GB9820405D0 (en)	1998-09-18	1998-11-11	Smithkline Beecham Plc	Process
EP1182193A4 (en) *	1999-04-09	2002-09-11	Mochida Pharm Co Ltd	REMEDIES FOR NEUROGENIC PAIN
GB9920919D0 (en)	1999-09-03	1999-11-10	Sb Pharmco Inc	Novel compound
GB9920917D0 (en)	1999-09-03	1999-11-10	Sb Pharmco Inc	Novel process
US6620830B2 (en) *	2000-04-21	2003-09-16	Pfizer, Inc.	Thyroid receptor ligands
YU27801A (sh) *	2000-04-28	2003-04-30	Pfizer Products Inc.	Postupak za dobijanje trihidrata mezilatne soli 1-(4- hidroksifenil)-2-(4-hidroksi-4-fenilpiperidin-1-il)-1-propanola i korisnih intermedijera
YU27701A (sh) *	2000-04-28	2003-04-30	Pfizer Products Inc.	Postupak za dobijanje trihidrata mezilatne soli 1-(4- hidroksifenil)-2-(4-hidroksi-4-fenilpiperidin-1-il)1-propanola
WO2002013807A2 (en)	2000-08-16	2002-02-21	Pharmacia & Upjohn Company	Compounds for the treatment of addictive disorders
EP1186303A3 (en) *	2000-09-06	2003-12-10	Pfizer Products Inc.	Pharmaceutical combinations, for the treatment of stroke and traumatic brain injury, containing a neutrophil inhibiting factor and an selective NMDA-NR2B receptor antagonist
IL145584A0 (en) *	2000-10-02	2002-06-30	Pfizer Prod Inc	Nmda nr2b antagonists for treatment
EP1674087A1 (en)	2000-10-02	2006-06-28	Pfizer Products Inc.	Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists
UA73619C2 (en) *	2000-12-13	2005-08-15	Pfizer Prod Inc	Stable pharmaceutical compositions of nmda receptor agonist (variants) and method of treatment
ES2287324T3 (es) *	2001-10-19	2007-12-16	Toyama Chemical Co., Ltd.	Derivados de alquil eter o sus sales.
KR100517638B1 (ko)	2002-04-08	2005-09-28	주식회사 엘지생명과학	게미플록사신 산염의 새로운 제조방법
CN103936690B (zh)	2005-10-25	2016-06-08	盐野义制药株式会社	氨基二氢噻嗪衍生物
RU2476430C2 (ru)	2007-04-24	2013-02-27	Сионоги Энд Ко., Лтд.	Производные аминодигидротиазина, замещенные циклической группой
WO2008133273A1 (ja)	2007-04-24	2008-11-06	Shionogi & Co., Ltd.	アルツハイマー症治療用医薬組成物
ES2738123T3 (es)	2008-06-13	2020-01-20	Shionogi & Co	Derivado heterocíclico que contiene azufre que tiene actividad inhibitoria de ß-secretasa
WO2010047372A1 (ja)	2008-10-22	2010-04-29	塩野義製薬株式会社	Ｂａｃｅ１阻害活性を有する２－アミノピリミジン－４－オンおよび２－アミノピリジン誘導体
WO2011071135A1 (ja)	2009-12-11	2011-06-16	塩野義製薬株式会社	オキサジン誘導体
US8927721B2 (en)	2010-10-29	2015-01-06	Shionogi & Co., Ltd.	Naphthyridine derivative
WO2012057247A1 (ja)	2010-10-29	2012-05-03	塩野義製薬株式会社	縮合アミノジヒドロピリミジン誘導体
JPWO2012147763A1 (ja)	2011-04-26	2014-07-28	塩野義製薬株式会社	オキサジン誘導体およびそれを含有するｂａｃｅ１阻害剤
EP2912035A4 (en)	2012-10-24	2016-06-15	Shionogi & Co	DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY
MX2017002775A (es)	2014-09-15	2017-08-10	Rugen Holdings (Cayman) Ltd	Derivados de pirrolopirimidina como antagonistas del receptor de n-metil-d-aspartato (nmda), subunidad nr2b.
US20180271869A1 (en) *	2014-09-22	2018-09-27	Jie Liu	Treatment of anxiety disorders and autism spectrum disorders
US10221182B2 (en)	2015-02-04	2019-03-05	Rugen Holdings (Cayman) Limited	3,3-difluoro-piperidine derivatives as NR2B NMDA receptor antagonists
CN107849010B (zh)	2015-06-01	2021-11-09	卢郡控股(开曼)有限公司	作为nr2b nmda受体拮抗剂的3,3‐二氟哌啶氨基甲酸酯杂环化合物
US11000526B2 (en)	2016-11-22	2021-05-11	Rugen Holdings (Cayman) Limited	Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5272160A (en) *	1989-05-17	1993-12-21	Pfizer Inc	2-piperidino-1-alkanol derivatives as antiischemic agents
WO1990014087A1 (en) *	1989-05-17	1990-11-29	Pfizer Inc.	2-piperidino-1-alkanol derivatives as antiischemic agents
NZ284852A (en) *	1994-08-18	1998-06-26	Pfizer	3-(piperidin-1-yl)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidin-1-yl) alkanol derivatives; medicaments; used as a neuroprotective agent
UA59341C2 (uk) *	1995-08-11	2003-09-15	Пфайзер, Інк.	(1s,2s)-1-(4-гідроксифеніл)-2-(4-гідрокси-4-фенілпіперидин-1-іл)-1-пропанолметансульфонат тригідрат

1996
- 1996-06-20 UA UA98020673A patent/UA59341C2/uk unknown
- 1996-06-20 AU AU59084/96A patent/AU710984B2/en not_active Ceased
- 1996-06-20 CZ CZ0039098A patent/CZ296236B6/cs not_active IP Right Cessation
- 1996-06-20 AT AT96916266T patent/ATE215072T1/de not_active IP Right Cessation
- 1996-06-20 ES ES96916266T patent/ES2170857T3/es not_active Expired - Lifetime
- 1996-06-20 DE DE69620191T patent/DE69620191T2/de not_active Expired - Fee Related
- 1996-06-20 PT PT96916266T patent/PT843661E/pt unknown
- 1996-06-20 EP EP96916266A patent/EP0843661B1/en not_active Expired - Lifetime
- 1996-06-20 KR KR1019980700989A patent/KR100291882B1/ko not_active Expired - Fee Related
- 1996-06-20 RO RO98-00231A patent/RO120134B1/ro unknown
- 1996-06-20 WO PCT/IB1996/000592 patent/WO1997007098A1/en not_active Ceased
- 1996-06-20 NZ NZ309134A patent/NZ309134A/en unknown
- 1996-06-20 CA CA002228752A patent/CA2228752C/en not_active Expired - Fee Related
- 1996-06-20 BR BR9610766A patent/BR9610766A/pt not_active Application Discontinuation
- 1996-06-20 CN CN96195649A patent/CN1198739A/zh active Pending
- 1996-06-20 JP JP09509083A patent/JP3099072B2/ja not_active Expired - Fee Related
- 1996-06-20 DK DK96916266T patent/DK0843661T3/da active
- 1996-06-20 CN CNA031584969A patent/CN1615861A/zh active Pending
- 1996-06-20 SK SK166-98A patent/SK284209B6/sk unknown
- 1996-06-20 RU RU98102116A patent/RU2140910C1/ru not_active IP Right Cessation
- 1996-06-20 TR TR1998/00208T patent/TR199800208T1/xx unknown
- 1996-06-20 IL IL12264996A patent/IL122649A/xx not_active IP Right Cessation
- 1996-06-20 HU HU9802862A patent/HUP9802862A3/hu unknown
- 1996-06-20 US US09/011,426 patent/US6008233A/en not_active Expired - Fee Related
- 1996-06-20 PL PL96325050A patent/PL185603B1/pl not_active IP Right Cessation
- 1996-06-24 TW TW085107571A patent/TW495502B/zh not_active IP Right Cessation
- 1996-07-04 GT GT199600051A patent/GT199600051A/es unknown
- 1996-07-23 SA SA96170171A patent/SA96170171B1/ar unknown
- 1996-08-06 PE PE1996000587A patent/PE4898A1/es not_active Application Discontinuation
- 1996-08-07 AR ARP960103904A patent/AR004676A1/es unknown
- 1996-08-07 TN TNTNSN96104A patent/TNSN96104A1/fr unknown
- 1996-08-07 DZ DZ960127A patent/DZ2083A1/fr active
- 1996-08-07 MA MA24335A patent/MA23957A1/fr unknown
- 1996-08-08 AP APAP/P/1996/000856A patent/AP755A/en active
- 1996-08-08 ZA ZA9606760A patent/ZA966760B/xx unknown
- 1996-08-09 HR HR960372A patent/HRP960372B1/xx not_active IP Right Cessation
- 1996-08-09 CO CO96042164A patent/CO4750830A1/es unknown
- 1996-08-09 RS YU46196A patent/RS49521B/sr unknown
1997
- 1997-12-30 IS IS4643A patent/IS1945B/is unknown
1998
- 1998-02-10 OA OA9800021A patent/OA10664A/en unknown
- 1998-02-10 NO NO19980574A patent/NO310458B1/no unknown
- 1998-02-27 BG BG102289A patent/BG63678B1/bg unknown

Also Published As

Publication number	Publication date
YU46196A (sh)	1999-07-28
HUP9802862A3 (en)	1999-05-28
JP3099072B2 (ja)	2000-10-16
AP755A (en)	1999-08-02
ATE215072T1 (de)	2002-04-15
DE69620191T2 (de)	2002-07-18
IS4643A (is)	1997-12-30
CO4750830A1 (es)	1999-03-31
NO310458B1 (no)	2001-07-09
HRP960372B1 (en)	2003-04-30
DK0843661T3 (da)	2002-07-22
CZ39098A3 (cs)	1999-02-17
PE4898A1 (es)	1998-03-16
RS49521B (sr)	2006-10-27
PT843661E (pt)	2002-07-31
AU5908496A (en)	1997-03-12
RO120134B1 (ro)	2005-09-30
BG63678B1 (bg)	2002-09-30
UA59341C2 (uk)	2003-09-15
US6008233A (en)	1999-12-28
NO980574D0 (no)	1998-02-10
SK284209B6 (en)	2004-11-03
WO1997007098A1 (en)	1997-02-27
CA2228752A1 (en)	1997-02-27
IS1945B (is)	2004-08-13
KR19990036321A (ko)	1999-05-25
HRP960372A2 (en)	1998-04-30
AU710984B2 (en)	1999-10-07
BR9610766A (pt)	1999-07-13
AP9600856A0 (en)	1996-10-31
JPH10510552A (ja)	1998-10-13
TR199800208T1 (no)	1998-05-21
GT199600051A (es)	1997-12-26
MX9801149A (es)	1998-05-31
CN1198739A (zh)	1998-11-11
PL325050A1 (en)	1998-07-06
CN1615861A (zh)	2005-05-18
AR004676A1 (es)	1999-03-10
BG102289A (en)	1998-09-30
KR100291882B1 (ko)	2001-10-26
NZ309134A (en)	1999-09-29
OA10664A (en)	2000-11-06
ZA966760B (en)	1998-02-09
DZ2083A1 (fr)	2002-10-23
SA96170171B1 (ar)	2006-05-20
MA23957A1 (fr)	1997-04-01
CZ296236B6 (cs)	2006-02-15
PL185603B1 (pl)	2003-06-30
HUP9802862A2 (hu)	1999-04-28
SK16698A3 (en)	1999-06-11
TNSN96104A1 (fr)	2005-03-15
IL122649A (en)	2001-08-26
EP0843661A1 (en)	1998-05-27
CA2228752C (en)	2002-12-10
IL122649A0 (en)	1998-08-16
ES2170857T3 (es)	2002-08-16
EP0843661B1 (en)	2002-03-27
RU2140910C1 (ru)	1999-11-10
DE69620191D1 (de)	2002-05-02
TW495502B (en)	2002-07-21

Publication	Publication Date	Title
NO980574D0 (no)	1998-02-10	(1S,2S)-1-(4-Hydroksyfenyl)-2-(4-hydroksy-4-fenylpiperidin-1-yl)-1-propanol-metansulfonattrihydrat
FI950715A0 (fi)	1995-02-17	Ytmikromekanisk, symmetrisk tryckskillnadsgivare
DE69606680D1 (de)	2000-03-23	1-Alpha, 26-dihydroxy-D-homo-vitamin D3
MX213693B (es)	2003-04-11	Polimero cationico.
FI960616A0 (fi)	1996-02-09	1-(2-(substituoitu-vinyyli))-3,4-dihydro-5H-2,3-bentsodiatsepiinijohdannaiset
DK0874814T3 (da)	2003-09-22	25-hydroxy-16-en-26,27-bishomo-cholecalciferoler
FR2718478B1 (fr)	1996-07-05	Plinthe démontable.
FR2720390B1 (fr)	1997-12-05	Machine sectionnelle.
ITBO970653A0 (it)	1997-10-31	Macchina bordatrice.
IT1297636B1 (it)	1999-12-20	Macchina per la lavorazione di legno.
FI1592U1 (fi)	1994-10-26	Spruta, foeretraedesvis injektionsspruta
ES1032571Y (es)	1996-11-01	Gafa,
IT1269022B (it)	1997-03-18	Tappo per operazioni di sfecciatura.
TR199600665A2 (tr)	1997-03-21	Asimetrik trifenilendioksazin bilesikleri.
IT1284728B1 (it)	1998-05-21	Macchina per dialisi.
ES1032948Y (es)	1996-12-01	Aplique.
UA10757A (uk)	1996-12-25	д.„Џ
IT234100Y1 (it)	2000-02-23	Macchina per vibromassaggi.
ES1028132Y (es)	1995-05-01	Maquina desbrozadora.
IT235626Y1 (it)	2000-07-12	Macchina per i trattamenti di biotermolisi.
ES1027687Y (es)	1995-03-01	Maquina paletizadora-despaletizadora.
ITTV940064V0 (it)	1994-12-01	Modello di calzatura, particolarmente per la pratica dello snowboard.
FI950956A0 (fi)	1995-03-01	Luftkabel, saosom haengspiralkabel
FI952416A0 (fi)	1995-05-18	Distributionsanordning foer vaetska, speciellt tvaettvaetska foer vindrutor
ES1034557Y (es)	1997-06-01	Cama-somier supletoria, apilable verticalmente.